{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:08:36Z","timestamp":1783908516971,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05313-w","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:04:29Z","timestamp":1776233069000},"page":"13009-13020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proton pump inhibitors and risk of Parkinson\u2019s disease: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0907-4475","authenticated-orcid":false,"given":"Hamdy A.","family":"Makhlouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5832-3780","authenticated-orcid":false,"given":"Obai","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9203-5107","authenticated-orcid":false,"given":"Omar","family":"Kassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0939-7923","authenticated-orcid":false,"given":"Mohamed A.","family":"Aldemerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9449-5707","authenticated-orcid":false,"given":"Haneen","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-6309","authenticated-orcid":false,"given":"Mostafa","family":"Meshref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"5313_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-81011-y","volume":"14","author":"N Alaeddin","year":"2024","unstructured":"Alaeddin N, Koch A, Etteldorf R et al (2024) The impact of proton pump inhibitors on brain health based on cross-sectional findings from the Rhineland Study. Sci Rep 14:30486. https:\/\/doi.org\/10.1038\/s41598-024-81011-y","journal-title":"Sci Rep"},{"key":"5313_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15:1257\u20131272. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7","journal-title":"Lancet Neurol"},{"key":"5313_CR3","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/aje\/kwae332","volume":"194","author":"R Brignardello-Petersen","year":"2025","unstructured":"Brignardello-Petersen R, Guyatt GH (2025) Assessing the certainty of the evidence in systematic reviews: importance, process, and use. Am J Epidemiol 194:1681\u20131686. https:\/\/doi.org\/10.1093\/aje\/kwae332","journal-title":"Am J Epidemiol"},{"key":"5313_CR4","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","volume":"25","author":"G Bruno","year":"2019","unstructured":"Bruno G, Zaccari P, Rocco G et al (2019) Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified. World J Gastroenterol 25:2706\u20132719. https:\/\/doi.org\/10.3748\/wjg.v25.i22.2706","journal-title":"World J Gastroenterol"},{"key":"5313_CR5","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central a nd enteric nervous systems. Ann Gastroenterol Q Publ Hell Soc Iety Gastroenterol 28:203\u2013209","journal-title":"Ann Gastroenterol Q Publ Hell Soc Iety Gastroenterol"},{"key":"5313_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31949","volume":"7","author":"JJ Chang","year":"2024","unstructured":"Chang JJ, Kulkarni S, Pasricha TS (2024) Upper gastrointestinal mucosal damage and subsequent risk of Parkinson disease. JAMA Netw Open 7:e2431949. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.31949","journal-title":"JAMA Netw Open"},{"key":"5313_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033711","volume":"102","author":"H-L Chen","year":"2023","unstructured":"Chen H-L, Lei W-Y, Wang J-H et al (2023) Proton pump inhibitor use and the risk for Parkinson\u2019s disease: a nationwide population-based study in Taiwan. Medicine (Baltimore) 102:e33711. https:\/\/doi.org\/10.1097\/MD.0000000000033711","journal-title":"Medicine (Baltimore)"},{"key":"5313_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01032-5","volume":"14","author":"HG Choi","year":"2022","unstructured":"Choi HG, Kim J-H, Kim JH et al (2022) Associations between proton pump inhibitors and Alzheimer\u2019s disease: a nested case\u2013control study using a Korean nationwide health screening cohort. Alzheimers Res Ther 14:91. https:\/\/doi.org\/10.1186\/s13195-022-01032-5","journal-title":"Alzheimers Res Ther"},{"key":"5313_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.arr.2016.05.004","volume":"32","author":"DJ Colacurcio","year":"2016","unstructured":"Colacurcio DJ, Nixon RA (2016) Disorders of lysosomal acidification\u2014the emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev 32:75\u201388. https:\/\/doi.org\/10.1016\/j.arr.2016.05.004","journal-title":"Ageing Res Rev"},{"key":"5313_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/archpediatrics.2009.31","volume":"163","author":"P Cummings","year":"2009","unstructured":"Cummings P (2009) The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med 163:438. https:\/\/doi.org\/10.1001\/archpediatrics.2009.31","journal-title":"Arch Pediatr Adolesc Med"},{"key":"5313_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2710.2009.01100.x","volume":"35","author":"MK Fallahzadeh","year":"2010","unstructured":"Fallahzadeh MK, Borhani Haghighi A, Namazi MR (2010) Proton pump inhibitors: predisposers to Alzheimer disease? J Clin Pharm Ther 35:125\u2013126. https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01100.x","journal-title":"J Clin Pharm Ther"},{"key":"5313_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M et al (2023) Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients 15:2211. https:\/\/doi.org\/10.3390\/nu15092211","journal-title":"Nutrients"},{"key":"5313_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne JJ, Power MC (2010) Anti-inflammatory drugs and risk of Parkinson disease. Neurology 74:995\u20131002. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d5a4a3","journal-title":"Neurology"},{"key":"5313_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","volume":"73","author":"W Gomm","year":"2016","unstructured":"Gomm W, Holt K, Thom\u00e9 F et al (2016) Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 73:410\u2013416. https:\/\/doi.org\/10.1001\/jamaneurol.2015.4791","journal-title":"JAMA Neurol"},{"key":"5313_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"5313_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions, 1st edn. Wiley","edition":"1st edn"},{"key":"5313_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295981","volume":"18","author":"JT Hong","year":"2023","unstructured":"Hong JT, Jung H-K, Lee KJ et al (2023) Potential risk of proton pump inhibitors for Parkinson\u2019s disease: a nationwide nested case-control study. PLoS One 18:e0295981. https:\/\/doi.org\/10.1371\/journal.pone.0295981","journal-title":"PLoS One"},{"key":"5313_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Goodrich JK, Maxan M-E et al (2016) Proton pump inhibitors alter the composition of the gut microbiota. Gut 65:749\u2013756. https:\/\/doi.org\/10.1136\/gutjnl-2015-310861","journal-title":"Gut"},{"key":"5313_CR19","doi-asserted-by":"crossref","unstructured":"John van Geest Centre for Brain Repair D of CN iences University of Cambridge, UK, Kouli A, Torsney KM, et al (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: John Van Geest Centre for Brain Repair D of CN iences University of Cambridge, UK, Stoker TB, Greenland JC, John Van Geest Centre for Brain Repair D of CN iences University of Cambridge, UK (eds) Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Codon Publications, pp 3\u201326","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"5313_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030327","volume":"15","author":"J-H Kim","year":"2022","unstructured":"Kim J-H, Oh J-K, Kim Y-H et al (2022) Association between proton pump inhibitor use and Parkinson\u2019s disease in a Korean population. Pharmaceuticals 15:327. https:\/\/doi.org\/10.3390\/ph15030327","journal-title":"Pharmaceuticals"},{"key":"5313_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28411","volume":"36","author":"EM Kline","year":"2021","unstructured":"Kline EM, Houser MC, Herrick MK et al (2021) Genetic and environmental factors in Parkinson\u2019s disease converge on immune function and inflammation. Mov Disord 36:25\u201336. https:\/\/doi.org\/10.1002\/mds.28411","journal-title":"Mov Disord"},{"key":"5313_CR22","doi-asserted-by":"publisher","unstructured":"Lai S-W (2020) Association between Parkinson\u2019s disease and proton pump inhibitors therapy in older people. BioMedicine. https:\/\/doi.org\/10.37796\/2211-8039.1048","DOI":"10.37796\/2211-8039.1048"},{"issue":"22","key":"5313_CR23","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam JR, Schneider JL, Zhao W, Corley DA (2013) Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 310:2435. https:\/\/doi.org\/10.1001\/jama.2013.280490","journal-title":"JAMA"},{"key":"5313_CR24","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.4103\/1673-5374.282252","volume":"15","author":"T Makunts","year":"2020","unstructured":"Makunts T, Abagyan R (2020) How can proton pump inhibitors damage central and peripheral nervous systems? Neural Regen Res 15:2041. https:\/\/doi.org\/10.4103\/1673-5374.282252","journal-title":"Neural Regen Res"},{"key":"5313_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149702","volume":"1861","author":"M Mohan","year":"2025","unstructured":"Mohan M, Mannan A, Singh S, Singh TG (2025) Unlocking the cellular mystery: how proton pump inhibitors may alter the dementia landscape. Brain Res 1861:149702. https:\/\/doi.org\/10.1016\/j.brainres.2025.149702","journal-title":"Brain Res"},{"key":"5313_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2710.2008.00907.x","volume":"33","author":"MR Namazi","year":"2008","unstructured":"Namazi MR, Jowkar F (2008) A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors. J Clin Pharm Ther 33:215\u2013217. https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00907.x","journal-title":"J Clin Pharm Ther"},{"key":"5313_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","volume":"93","author":"AK Nehra","year":"2018","unstructured":"Nehra AK, Alexander JA, Loftus CG, Nehra V (2018) Proton pump inhibitors: review of emerging concerns. Mayo Clin Proc 93:240\u2013246. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.022","journal-title":"Mayo Clin Proc"},{"key":"5313_CR28","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1093\/jn\/127.12.2282","volume":"127","author":"C Nelson","year":"1997","unstructured":"Nelson C, Erikson K, Pi\u00f1ero DJ, Beard JL (1997) In vivo dopamine metabolism is altered in iron-deficient anemic rats. J Nutr 127:2282\u20132288. https:\/\/doi.org\/10.1093\/jn\/127.12.2282","journal-title":"J Nutr"},{"key":"5313_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1468-1331.2011.03643.x","volume":"19","author":"HH Nielsen","year":"2012","unstructured":"Nielsen HH, Qiu J, Friis S et al (2012) Treatment for Helicobacter pylori infection and risk of Parkinson\u2019s disease in Denmark. Eur J Neurol 19:864\u2013869. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03643.x","journal-title":"Eur J Neurol"},{"key":"5313_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00415-025-13138-5","volume":"272","author":"PJ Oliver","year":"2025","unstructured":"Oliver PJ, Civitelli L, Hu MT (2025) The gut\u2013brain axis in early Parkinson\u2019s disease: from prodrome to prevention. J Neurol 272:413. https:\/\/doi.org\/10.1007\/s00415-025-13138-5","journal-title":"J Neurol"},{"key":"5313_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9:776847. https:\/\/doi.org\/10.3389\/fpubh.2021.776847","journal-title":"Front Public Health"},{"key":"5313_CR32","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"5313_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"5313_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00228-018-2561-y","volume":"75","author":"TN Poly","year":"2019","unstructured":"Poly TN, Islam MMR, Yang H-C, Li Y-C (2019) Non-steroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease in the elderly population: a meta-analysis. Eur J Clin Pharmacol 75:99\u2013108. https:\/\/doi.org\/10.1007\/s00228-018-2561-y","journal-title":"Eur J Clin Pharmacol"},{"key":"5313_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"5313_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","volume":"50","author":"S Salim","year":"2022","unstructured":"Salim S, Ahmad F, Banu A, Mohammad F (2022) Gut microbiome and Parkinson\u2019s disease: perspective on pathogenesis an d treatment. J Adv Res 50:83\u2013105. https:\/\/doi.org\/10.1016\/j.jare.2022.10.013","journal-title":"J Adv Res"},{"key":"5313_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","volume":"176","author":"AJ Schoenfeld","year":"2016","unstructured":"Schoenfeld AJ, Grady D (2016) Adverse effects associated with proton pump inhibitors. JAMA Intern Med 176:172\u2013174. https:\/\/doi.org\/10.1001\/jamainternmed.2015.7927","journal-title":"JAMA Intern Med"},{"key":"5313_CR38","doi-asserted-by":"publisher","unstructured":"Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson\u2019s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112\u20131118. https:\/\/doi.org\/10.1002\/1531-8257(200011)15:6%253C1112::AID-MDS1008%253E3.0.CO;2-A","DOI":"10.1002\/1531-8257(200011)15:6%253C1112::AID-MDS1008%253E3.0.CO;2-A"},{"key":"5313_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030891","volume":"19","author":"N Shirafuji","year":"2018","unstructured":"Shirafuji N, Hamano T, Yen S-H et al (2018) Homocysteine increases tau phosphorylation, truncation and oligomerization. Int J Mol Sci 19:891. https:\/\/doi.org\/10.3390\/ijms19030891","journal-title":"Int J Mol Sci"},{"key":"5313_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"5313_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002. https:\/\/doi.org\/10.1136\/bmj.d4002","journal-title":"BMJ"},{"key":"5313_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.878239","author":"X Sun","year":"2022","unstructured":"Sun X, Xue L, Wang Z, Xie A (2022) Update to the treatment of Parkinson\u2019s disease based on the gut-brain axis mechanism. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2022.878239","journal-title":"Front Neurosci"},{"key":"5313_CR43","doi-asserted-by":"publisher","unstructured":"Xie K, Li J, Tang C et al (2024) Association between proton pump inhibitors and dementia risk: a Mendelian randomization study. Sci Rep 14:28624. https:\/\/doi.org\/10.1038\/s41598-024-79821-1","DOI":"10.1038\/s41598-024-79821-1"},{"key":"5313_CR44","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","volume":"118","author":"G Yepuri","year":"2016","unstructured":"Yepuri G, Sukhovershin R, Nazari-Shafti TZ et al (2016) Proton pump inhibitors accelerate endothelial senescence. Circ Res 118:e36\u2013e42. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308807","journal-title":"Circ Res"},{"key":"5313_CR45","unstructured":"Zafar S, Yaddanapudi SS (2023) Parkinson disease. In: StatPearls [Internet]. StatPearls Publishing"},{"key":"5313_CR46","unstructured":"Zuvarox T, Goosenberg E, Belletieri C (2025) Malabsorption syndromes. [Updated 2025 Jul 7]. In: StatPearls [Internet]."}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05313-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:44:23Z","timestamp":1783907063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05313-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5313"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05313-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors\u2019 consent has been obtained by the corresponding author for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests. None of the authors received payments or services via his or her institution or from third parties.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}